Sector Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.130 USD | +0.32% |
|
-0.95% | +13.82% |
| Aug. 19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 357M | - | ||||
| 48.41B | |||||
| 45.01B | - | - | - | - | - |
| 44.07B | |||||
| 40.73B | |||||
| 33.21B |
Select your edition
All financial news and data tailored to specific country editions
